Your browser doesn't support javascript.
loading
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status.
Roboz, Gail J; Ravandi, Farhad; Wei, Andrew H; Dombret, Hervé; Thol, Felicitas; Voso, Maria Teresa; Schuh, Andre C; Porkka, Kimmo; La Torre, Ignazia; Skikne, Barry; Zhong, Jianhua; Beach, C L; Risueño, Alberto; Menezes, Daniel L; Ossenkoppele, Gert; Döhner, Hartmut.
Afiliação
  • Roboz GJ; Weill Cornell Medicine, New York, NY.
  • Ravandi F; New York Presbyterian Hospital, New York, NY.
  • Wei AH; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dombret H; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia.
  • Thol F; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
  • Voso MT; Hematology, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
  • Schuh AC; Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Porkka K; Medizinische Hochschule Hannover, Hannover, Germany.
  • La Torre I; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Skikne B; Princess Margaret Cancer Centre, Toronto, Canada.
  • Zhong J; Hospital District of Helsinki and Uusimaa (HUS) Comprehensive Cancer Center, Hematology Research Unit Helsinki and iCAN Digital Precision Cancer Center Medicine Flagship, University of Helsinki, Finland.
  • Beach CL; Celgene, a Bristol Myers Squibb Company, Boudry, Switzerland.
  • Risueño A; Division of Hematologic Malignancies and Cellular Therapeutics, BMS, Princeton, NJ.
  • Menezes DL; Bristol Myers Squibb, University of Kansas Medical Center, Kansas City, KS.
  • Ossenkoppele G; Division of Hematologic Malignancies and Cellular Therapeutics, BMS, Princeton, NJ.
  • Döhner H; Division of Hematologic Malignancies and Cellular Therapeutics, BMS, Princeton, NJ.
Blood ; 139(14): 2145-2155, 2022 04 07.
Article em En | MEDLINE | ID: mdl-34995344
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article